Article
Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects.
BMC biotechnology - 8 Nov 2019
Zheng Guoxing, Zhu Qingqing, Dong Junchao, Lin Xin, Zhu Chengming
Abstract excerpt
BACKGROUND: Genetic mutations cause severe human diseases, and suitable animal models to study the regulatory mechanisms involved are required. The CRISPR/Cas9 system is a powerful, highly efficient and easily manipulated tool for genetic modifications. However, utilization of CRISPR/Cas9 to introduce point mutations and the exclusion of off-target effects in mice remain challenging. TP53-R175 is one of the most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
